QuadraMed Corporation Appoints New Director
20 February 2008 - 4:46AM
Business Wire
QuadraMed� Corporation (Amex:QD) today named Julian A.L. Allen to
its Board of Directors, expanding the Board from five to six
members. Mr. Allen is the Founder of Spitfire Capital LLC, a San
Francisco-based investment advisor, and Managing Partner of The
Spitfire Fund LP, which owns 560,600 shares of QuadraMed�s common
stock, representing approximately 1.3% of the Company�s outstanding
common stock. "Julian�s deep financial and investment expertise, as
well as his in-depth knowledge of QuadraMed, provides him with a
unique perspective,� said Keith Hagen, QuadraMed�s president and
CEO. �We are delighted to welcome Julian to our Board and
anticipate that his Wall Street experience will be invaluable as we
execute on our growth strategies and expand our investor relations
initiatives.� �QuadraMed is a leader in providing information
technology solutions that improve clinical and financial outcomes
for healthcare providers,� said Mr. Allen. �I am looking forward to
working with the board of directors and management team to help
QuadraMed leverage the many opportunities that lie ahead.� Before
founding Spitfire Capital, Mr. Allen was a member of Cannell
Capital LLC and its affiliate, OneFifty LLC, a San Francisco hedge
fund advisor. Prior to joining Cannell Capital, Mr. Allen was a
Managing Director of J.H. Whitney & Co., LLC, a private equity
and alternative investment management firm where he focused on
private equity investments in the financial services, business
services, healthcare services and technology industries.
Previously, Mr. Allen held various positions at Capital Z Partners,
Patricof & Co. Ventures, Inc., and Wasserstein Perella &
Co., Inc. Mr. Allen received his Master of Business Administration
degree with High Distinction from Harvard Business School and a
Bachelor of Arts degree from Cambridge University. About QuadraMed
Corporation QuadraMed Corporation advances the success of
healthcare organizations through IT solutions that leverage quality
care into positive financial outcomes. QuadraMed provides real
world solutions that help healthcare professionals deliver
outstanding patient care efficiently and cost effectively. Behind
the company�s products and services is a staff of 650 professionals
whose experience and dedication have earned QuadraMed the trust and
loyalty of clients at over 2,000 healthcare provider facilities.
For more information about QuadraMed, visit
http://www.quadramed.com/. Cautionary Statement on Risks Associated
with QuadraMed Forward-Looking Statements This press release
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 by QuadraMed that
are subject to risks and uncertainties. The words "believe,"
"expect," "anticipate," "intend," "plan," "estimate," "may,"
"should," "could," and similar expressions are intended to identify
such statements. Forward-looking statements are not guarantees of
future performance and are to be interpreted only as of the date on
which they are made. QuadraMed undertakes no obligation to update
or revise any forward-looking statement except as required by law.
QuadraMed advises investors that it discusses risk factors and
uncertainties that could cause QuadraMed�s actual results to differ
from forward-looking statements in its periodic reports filed with
the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC
filings can be accessed through the Investor Relations section of
our website, www.quadramed.com, or through the SEC�s EDGAR Database
at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed
is a registered trademark of QuadraMed Corporation. All other
trademarks are the property of their respective holders.
Quadramed (AMEX:QD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Quadramed (AMEX:QD)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Quadramed Corp. (American Stock Exchange): 0 recent articles
More QuadraMed Corporation News Articles